As of 2025-05-17, the Intrinsic Value of OncoSec Medical Inc (ONCS) is -49.96 USD. This ONCS valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.28 USD, the upside of OncoSec Medical Inc is -18,122.11%.
Based on its market price of 0.28 USD and our intrinsic valuation, OncoSec Medical Inc (ONCS) is overvalued by 18,122.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -49.96 - -49.96 | -49.96 | -18,122.11% |
| P/E | (53.65) - (105.82) | (83.40) | -30188.3% |
| DDM - Stable | (36.32) - (156.55) | (96.43) | -34888.4% |
| DDM - Multi | (29.57) - (108.49) | (47.58) | -17265.1% |
| Market Cap (mil) | 1.65 |
| Beta | -0.12 |
| Outstanding shares (mil) | 5.96 |
| Enterprise Value (mil) | 0.26 |
| Market risk premium | 5.00% |
| Cost of Equity | 11.17% |
| Cost of Debt | 5.00% |
| WACC | 8.85% |